Literature DB >> 28332054

A Mesiotemporal Lobe Epilepsy Mouse Model.

Duveau Venceslas1, Roucard Corinne2.   

Abstract

Among the different forms of epilepsies, mesiotemporal lobe epilepsy (MTLE) is one of the most common and represents the main pharmaco-resistant form of epilepsy. There is therefore an urgent need to better understand this form of epilepsy to develop better anti-epileptic drugs. Many rodent models are mimicking some aspects of the human temporal lobe epilepsy but only few are addressing most of the human mesiotemporal lobe epilepsy. In this article, we describe the main characteristics of a mouse of model of mesial temporal lobe epilepsy. This model is generated by a single injection of kainic acid into the dorsal hippocampus which reproduces most of the morphological and electrophysiological features of human MTLE in a mouse. This model may help to better understand mesial temporal lobe epilepsy and the development of new therapeutic drugs.

Entities:  

Keywords:  Epileptic discharges; Hippocampus; Kainic acid; Mouse models

Mesh:

Substances:

Year:  2017        PMID: 28332054     DOI: 10.1007/s11064-017-2239-3

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  40 in total

1.  Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop.

Authors:  James P Stables; Ed Bertram; F E Dudek; Greg Holmes; Gary Mathern; Asla Pitkanen; H S White
Journal:  Epilepsia       Date:  2003-12       Impact factor: 5.864

2.  Neurochemical remodelling of the hippocampus in human temporal lobe epilepsy.

Authors:  N C de Lanerolle; M L Brines; J H Kim; A Williamson; M F Philips; D D Spencer
Journal:  Epilepsy Res Suppl       Date:  1992

3.  Inflammatory changes during epileptogenesis and spontaneous seizures in a mouse model of mesiotemporal lobe epilepsy.

Authors:  Fabien Pernot; Christophe Heinrich; Laure Barbier; André Peinnequin; Pierre Carpentier; Franck Dhote; Valérie Baille; Claire Beaup; Antoine Depaulis; Frédéric Dorandeu
Journal:  Epilepsia       Date:  2011-09-28       Impact factor: 5.864

4.  Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy.

Authors:  C R Houser
Journal:  Brain Res       Date:  1990-12-10       Impact factor: 3.252

5.  Antiepileptic drug treatment in seizure-free mesial temporal lobe epilepsy patients with hippocampal sclerosis following selective amygdalohippocampectomy.

Authors:  Heinz Gregor Wieser; Adrian Häne
Journal:  Seizure       Date:  2004-12       Impact factor: 3.184

6.  Significant effects of sex, strain, and anesthesia in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.

Authors:  Friederike Twele; Kathrin Töllner; Claudia Brandt; Wolfgang Löscher
Journal:  Epilepsy Behav       Date:  2015-12-28       Impact factor: 2.937

7.  Frequency, prognosis and surgical treatment of structural abnormalities seen with magnetic resonance imaging in childhood epilepsy.

Authors:  Anne T Berg; Gary W Mathern; Richard A Bronen; Robert K Fulbright; Francis DiMario; Francine M Testa; Susan R Levy
Journal:  Brain       Date:  2009-07-28       Impact factor: 13.501

8.  Atrophy of mesial structures in patients with temporal lobe epilepsy: cause or consequence of repeated seizures?

Authors:  F Cendes; F Andermann; P Gloor; I Lopes-Cendes; E Andermann; D Melanson; M Jones-Gotman; Y Robitaille; A Evans; T Peters
Journal:  Ann Neurol       Date:  1993-12       Impact factor: 10.422

9.  Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat.

Authors:  Véronique André; Marie-Aude Rigoulot; Estelle Koning; Arielle Ferrandon; Astrid Nehlig
Journal:  Epilepsia       Date:  2003-07       Impact factor: 5.864

10.  Granule cell dispersion develops without neurogenesis and does not fully depend on astroglial cell generation in a mouse model of temporal lobe epilepsy.

Authors:  Naoki Nitta; Christophe Heinrich; Hisao Hirai; Fumio Suzuki
Journal:  Epilepsia       Date:  2008-04-03       Impact factor: 5.864

View more
  5 in total

1.  Chemogenetic Seizure Control with Clozapine and the Novel Ligand JHU37160 Outperforms the Effects of Levetiracetam in the Intrahippocampal Kainic Acid Mouse Model.

Authors:  Jana Desloovere; Paul Boon; Lars Emil Larsen; Marie-Gabrielle Goossens; Jean Delbeke; Evelien Carrette; Wytse Wadman; Kristl Vonck; Robrecht Raedt
Journal:  Neurotherapeutics       Date:  2021-12-03       Impact factor: 6.088

2.  Pronounced antiseizure activity of the subtype-selective GABAA positive allosteric modulator darigabat in a mouse model of drug-resistant focal epilepsy.

Authors:  Rachel Gurrell; Philip Iredale; Alexis Evrard; Venceslas Duveau; Céline Ruggiero; Corinne Roucard
Journal:  CNS Neurosci Ther       Date:  2022-08-14       Impact factor: 7.035

Review 3.  Role of Adenosine in Epilepsy and Seizures.

Authors:  Fabio C Tescarollo; Diogo M Rombo; Lindsay K DeLiberto; Denise E Fedele; Enmar Alharfoush; Ângelo R Tomé; Rodrigo A Cunha; Ana M Sebastião; Detlev Boison
Journal:  J Caffeine Adenosine Res       Date:  2020-06-04

4.  A companion to the preclinical common data elements for pharmacologic studies in animal models of seizures and epilepsy. A Report of the TASK3 Pharmacology Working Group of the ILAE/AES Joint Translational Task Force.

Authors:  Melissa Barker-Haliski; Lauren C Harte-Hargrove; Teresa Ravizza; Ilse Smolders; Bo Xiao; Claudia Brandt; Wolfgang Löscher
Journal:  Epilepsia Open       Date:  2018-09-15

Review 5.  Animal Models of Epilepsy: A Phenotype-oriented Review.

Authors:  Yilin Wang; Penghu Wei; Feng Yan; Yumin Luo; Guoguang Zhao
Journal:  Aging Dis       Date:  2022-02-01       Impact factor: 6.745

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.